Clinical Trials
249 trialsROR
Abramson Cancer Center at Penn Medicine
Risk Communication Within Mexican-American Families
National Institutes of Health Clinical Center (CC)
Gulf Long-Term Follow-Up Study
National Institutes of Health Clinical Center (CC)
Developing the Family Map: Looking at Communal Coping
National Institutes of Health Clinical Center (CC)
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
BRAVO
Hospital Alemão Oswaldo Cruz
Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors
University of Southern Queensland
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
Asan Medical Center
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
National Institutes of Health Clinical Center (CC)
G-COR
The Cleveland Clinic
HAPIN
Emory University
HER-CROWN
Ottawa Heart Institute Research Corporation
Cancer and Blood Pressure Management, CARISMA Study
Eastern Cooperative Oncology Group
Physical Capacity in Hodgkin Lymphoma Survivors
University of Sao Paulo General Hospital
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
University of Michigan Rogel Cancer Center
100-Year Human Aging Study
Longevity Metrics, Inc.
AH-HA
Wake Forest University Health Sciences
GRACE
Duke University
GC-PRO Intervention
University of Minnesota
BEAMER
Technical University of Madrid
HEALTHY-AYA
Duke University
RISP
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
PCT
Abramson Cancer Center at Penn Medicine
NUTPOOL
Institut Investigacio Sanitaria Pere Virgili
PULSE
Dana-Farber Cancer Institute
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
Peking Union Medical College Hospital
Mediterranean Diet and Physical Activity in Breast Cancer Patients Under Hormone Therapy
University of Oran 1
Food and Microbiome Longitudinal Investigation (FAMiLI)
NYU Langone Health
ONE TEAM
Duke University
ALDH2 Genetic Testing in East Asian Community
Northwestern University
COTIRA
University of Aarhus
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
Advanced Imaging Holistic Omics Biobank
IRCCS San Raffaele
Home-Based Measures of Physical Activity and Body Composition
M.D. Anderson Cancer Center
COUNTS2
University of California, San Francisco
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Pfizer
Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy
Connecticut Children's Medical Center
A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
Roswell Park Cancer Institute
HYDRA
Leiden University Medical Center
The True Face of the Pyramid; Physical Activity Level and Cardiovascular Risk in Patients With Breast Cancer
Hacettepe University
Zanubrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies
University Hospital, Caen
Strive Cardio for Endometrial Cancer Survivors
University of Iowa
WB2020
Colorado State University
VITAL
Brigham and Women's Hospital
CCT2
Abramson Cancer Center at Penn Medicine
ActivityChoice: Implementing Clinic-Based Physical Activity Program Choices for Cancer Survivors
University of Massachusetts, Worcester
CLARITY
Abramson Cancer Center at Penn Medicine
TIROVASC
Istituto Auxologico Italiano
Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China
Huazhong University of Science and Technology
COSMOS
Brigham and Women's Hospital